Hospira Inc., A Pfizer Company recalls Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL (5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc.
Recalled October 19, 2016 · FDA recall D-0097-2017 · Hospira Inc., A Pfizer
Hazard
Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency. · FDA Class II
Units
4768 vials
Sold at
Nationwide and Puerto Rico
Description
Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.
Product
Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL (5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1610-50.
Manufacturer(s)
Hospira Inc., A Pfizer Company
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →